Search research articles
Contact Us
Filters
Showing results (31-40 of 180) with videos related to
Page
of 18
Sort By:
Current Protocols in Human Genetics
|
April 23, 2008
Development of molecular genetic interventions for HIV infection
C Woffendin, U Ranga, G J Nabel
Proceedings of the National Academy of Sciences of the United States of America
|
April 1, 1989
Tumor necrosis factor alpha and interleukin 1 stimulate the human immunodeficiency virus enhancer by activation of the nuclear factor kappa B
L Osborn, S Kunkel, G J Nabel
Journal of Virology
|
September 1, 1989
NF-kappa B-mediated activation of the human immunodeficiency virus enhancer: site of transcriptional initiation is independent of the TATA box
A Bielinska, S Krasnow, G J Nabel
Proceedings of the National Academy of Sciences of the United States of America
|
May 1, 1988
T-cell-specific expression of interleukin 2: evidence for a negative regulatory site
G J Nabel, C Gorka, D Baltimore
Science (New York, N.Y.)
|
November 30, 1998
Regulation of the proinflammatory effects of Fas ligand (CD95L)
J J Chen, Y Sun, G J Nabel
The New Biologist
|
July 1, 1991
Selective elimination of recombinant genes in vivo with a suicide retroviral vector
G Plautz, E G Nabel, G J Nabel
Journal of the American College of Cardiology
|
May 1, 1991
Gene transfer into vascular cells
E G Nabel, G Plautz, G J Nabel
Journal of Virology
|
April 20, 2001
Human immunodeficiency virus type 1-specific immunity after genetic immunization is enhanced by modification of Gag and Pol expression
Y Huang, W P Kong, G J Nabel
Science (New York, N.Y.)
|
September 14, 1990
Site-specific gene expression in vivo by direct gene transfer into the arterial wall
E G Nabel, G Plautz, G J Nabel
Molecular Medicine (Cambridge, Mass.)
|
November 1, 1996
Mechanisms of tumor-induced immunosuppression: evidence for contact-dependent T cell suppression by monocytes
M L Jaffe, H Arai, G J Nabel
Page
of 18
Search research articles
Search
Showing results (31-40 of 180) with videos related to
Sort By:
Page
of 18
Current Protocols in Human Genetics
|
April 23, 2008
Development of molecular genetic interventions for HIV infection
C Woffendin, U Ranga, G J Nabel
Proceedings of the National Academy of Sciences of the United States of America
|
April 1, 1989
Tumor necrosis factor alpha and interleukin 1 stimulate the human immunodeficiency virus enhancer by activation of the nuclear factor kappa B
L Osborn, S Kunkel, G J Nabel
Journal of Virology
|
September 1, 1989
NF-kappa B-mediated activation of the human immunodeficiency virus enhancer: site of transcriptional initiation is independent of the TATA box
A Bielinska, S Krasnow, G J Nabel
Proceedings of the National Academy of Sciences of the United States of America
|
May 1, 1988
T-cell-specific expression of interleukin 2: evidence for a negative regulatory site
G J Nabel, C Gorka, D Baltimore
Science (New York, N.Y.)
|
November 30, 1998
Regulation of the proinflammatory effects of Fas ligand (CD95L)
J J Chen, Y Sun, G J Nabel
The New Biologist
|
July 1, 1991
Selective elimination of recombinant genes in vivo with a suicide retroviral vector
G Plautz, E G Nabel, G J Nabel
Journal of the American College of Cardiology
|
May 1, 1991
Gene transfer into vascular cells
E G Nabel, G Plautz, G J Nabel
Journal of Virology
|
April 20, 2001
Human immunodeficiency virus type 1-specific immunity after genetic immunization is enhanced by modification of Gag and Pol expression
Y Huang, W P Kong, G J Nabel
Science (New York, N.Y.)
|
September 14, 1990
Site-specific gene expression in vivo by direct gene transfer into the arterial wall
E G Nabel, G Plautz, G J Nabel
Molecular Medicine (Cambridge, Mass.)
|
November 1, 1996
Mechanisms of tumor-induced immunosuppression: evidence for contact-dependent T cell suppression by monocytes
M L Jaffe, H Arai, G J Nabel
Page
of 18